Ltb-ng6
Phase 1
Ltb-ng6 is one of 9 therapeutic programs targeting Gonorrhea. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
9 competitors in Gonorrhea
#DrugCompanyPhaseTrials
1Cipro
BayerApproved
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Garamycin
SSchering-Plough
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Factive
LLG Chem
Approved
Menacwy Liquid
GSKPreclinical
Ltb-ng6
LLimmaTech Biologics AG
Phase 1
Trumenba
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Ltb-ng6. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 1[1]
- Company
- LLimmaTech Biologics AG